News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Daily News UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI L.A. McKeown February 06, 2024
News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022
News Daily News FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries Shelley Wood February 16, 2021
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins Todd Neale September 19, 2016
News Industry News Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease September 16, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Daily News Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration Michael O'Riordan June 13, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Industry News Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease March 01, 2016